Gryphon Financial Partners LLC Bristol Myers Squibb CO Transaction History

Gryphon Financial Partners LLC

$665 Million
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$47.98 - $54.4 $22,550 - $25,568	-470 Reduced 8.98%	4,765 $258,000
Q4 2023 Feb 06, 2024	BUY	$48.48 - $57.85 $48,237 - $57,560	995 Added 23.47%	5,235 $268,000
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $38,438 - $42,980	664 Added 18.57%	4,240 $246,000
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $112,639 - $125,068	-1,768 Reduced 33.08%	3,576 $228,000
Q1 2023 May 03, 2023	SELL	$65.71 - $74.53 $34,760 - $39,426	-529 Reduced 9.01%	5,344 $370,000
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $35,678 - $42,247	-521 Reduced 8.15%	5,873 $422,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $77 - $45,719	595 Added 10.26%	6,394 $454,000
Q2 2022 Jul 28, 2022	BUY	$72.62 - $79.98 $116,119 - $127,888	1,599 Added 38.07%	5,799 $447,000
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $4,365 - $5,234	71 Added 1.72%	4,200 $307,000
Q4 2021 Feb 01, 2022	SELL	$53.63 - $62.52 $16,786 - $19,568	-313 Reduced 7.05%	4,129 $257,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $32,661 - $38,259	-552 Reduced 11.05%	4,442 $262,000
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $55,904 - $60,880	903 Added 22.07%	4,994 $321,000
Q1 2021 May 05, 2021	BUY	$59.34 - $66.74 $1,780 - $2,002	30 Added 0.74%	4,091 $257,000
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $34,874 - $39,519	-604 Reduced 12.95%	4,061 $252,000
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $267,910 - $296,880	4,665 New	4,665 $282,000
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $253,597 - $296,480	-4,626 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $83,241 - $120,969	-1,794 Reduced 27.94%	4,626 $257,000
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $315,928 - $412,099	6,420 New	6,420 $412,000
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $287,293 - $372,551	-5,892 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$55.19 - $62.25 $179,809 - $202,810	3,258 Added 123.69%	5,892 $366,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $8,084 - $10,076	-160 Reduced 5.73%	2,634 $146,000
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $2,037 - $2,345	-34 Reduced 1.2%	2,794 $177,000
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $169,510 - $184,809	2,828	2,828 $173,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gryphon Financial Partners LLC with notifications on news.

Account